JCR Pharma’s Drug Development “Let’s give it a shot !”
2022 Volume 32 Issue 1 Pages 7-11
Details
2022 Volume 32 Issue 1 Pages 7-11
JCR Pharmaceuticals was established in 1975 by Shin Ashida, who is the current Chairman, President and CEO. Since its establishment, JCR has consistently devoted itself to biotechnology industry. At the time of foundation, JCR developed its capability of protein purification by isolating bioactive protein from urine, and then put their focus on recombinant protein medicine by gene modification. Throughout the years, JCR has been working in the spirit of “Let’s give it a shot!”, which led to a success of creating its original technology. Today JCR is enhancing development in rare disease area with its proprietary technology. JCR is also working on cell therapy, regenerative medicine and gene therapy to develop a game-changing new drug. In this article, we would like to overview history of research and drug development at JCR and also introduce opportunities in the future.
